SLSNSLSNConsumer Defensive · Household & Personal Products

SLSN Stock Forecast: Solesence, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026
$0.99
+19.29% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 22 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap
$70.6M
Ticker Nerd rank
22 / 100
Median analyst target
Analysts covering
Total return, dividends reinvested
1W
+6.5%
1M
+45.6%
YTD
−38.1%
1Y
−64.4%
From 52W high
−77.3%
From 52W low
+54.7%
$0.64
$4.36
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SLSN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Solesence, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026
22 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
80
Issuance
61
Quality
54
Accruals
53
Value
39
Revisions
25
Growth
20
Volatility
8
Momentum
3

Size (80): Smaller than most of the companies we track.

Momentum (3): The shares have been drifting down relative to others.

The rank is the raw material. Whether the rules would actually own Solesence, Inc. — and when they’d sell — is the membership.

Wall Street

SLSN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SLSN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$1.00$2.00$3.00$4.00Oct 25Jan 26Apr 26Jul 26SLSN

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

SLSN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Solesence, Inc. (SLSN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
99.0×

Cheaper than 7% of US stocks

Price / sales
1.2×

Cheaper than 66% of US stocks

Price / book
4.1×

Cheaper than 25% of US stocks

EV / EBITDA
44.7×

Cheaper than 6% of US stocks

Growth & margins
Revenue growth (YoY)
−11.4%

Higher than 15% of US stocks

Earnings growth (YoY)
−11.4%

Higher than 25% of US stocks

Gross margin
25.8%

Higher than 31% of US stocks

Operating margin
−3.9%

Higher than 31% of US stocks

Net margin
1.6%

Higher than 51% of US stocks

Returns & dividend
Return on equity
5.9%

Higher than 55% of US stocks

Return on assets
1.0%

Higher than 49% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SLSN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
SLSNSolesence, Inc.$70.6M
22
GROVGrove Collaborative Holdings, Inc.$46.2M
97
SKINSkinhealth Systems, Inc.$87.6M
91
UGUnited-Guardian, Inc.$32.4M
78
DSYBig Tree Cloud Holdings Ltd.$31.1M
4
RAYRaytech Holding Ltd.$16.2M
8
ACUAcme United Corp.$216.0M
97
Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SLSN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

News

Latest SLSN news & analysis

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

GlobeNewsWire · 28 July 2026neutral

Solésence, Inc. announced it will report second quarter 2026 financial results before the market opens on August 11, 2026, and will host a conference call and webcast the same day.

Why it matters — The announcement provides the date and time for SLSN's next quarterly earnings release and investor call, which will disclose the company's financial performance for the period.

FAQ

Frequently asked questions about SLSN stock

How does Ticker Nerd's model rank SLSN?

As at 1 Aug 2026, Solesence, Inc. ranks 22 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (80 of 100).

What is the SLSN stock forecast for 2030?

No analyst covering Solesence, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SLSN are extrapolating price history, which says nothing about the business.

How has SLSN stock performed over the past year?

Solesence, Inc. returned -64.4% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Solesence, Inc. do?

Solesence Inc. is a science-driven company specializing in the development and manufacture of mineral-based skincare and makeup products, with a particular focus on sun care and skin health.

What is the latest news on SLSN?

The most recent item we track (GlobeNewsWire, 28 July 2026): "Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11". Solésence, Inc. announced it will report second quarter 2026 financial results before the market opens on August 11, 2026, and will host a conference call and webcast the same day.

Company

About Solesence, Inc.

Solesence Inc. is a science-driven company specializing in the development and manufacture of mineral-based skincare and makeup products, with a particular focus on sun care and skin health. Originating from its predecessor, Nanophase Technologies Corporation, the company utilizes advanced materials engineering to create proprietary active pharmaceutical ingredients that deliver UV protection and environmental defense for the beauty and personal care sectors. Solesence partners with both global and independent brands, offering turnkey product development and custom solutions that emphasize clean, inclusive formulations. Its technological suite, including Active Stress Defense™, underpins a broad range of award-winning, patent-protected products recognized across the cosmetics industry. In addition to consumer-focused skincare formulations, Solesence also supplies engineered zinc oxide and titanium dioxide materials for use in sunscreens and other personal care applications. With manufacturing operations rooted in the United States and a strong commitment to quality, regulatory compliance, and innovation, Solesence plays a pivotal role in advancing mineral-based protection and skincare within the beauty market, supporting both established and emerging brands with expertise and scalability.

CEO Mr. Kevin Cureton · 115 employees · United States · https://solesence.com